Objective: Niemann-Pick disease type C (NPC) is a progressive neurovisceral disorder with disrupted intracellular cholesterol metabolism that results in significant alterations to neuronal and axonal structure. Adult patients present with ataxia, gaze palsy, impaired cognition, and neuropsychiatric illness, but the neural substrate has not been well-characterized in vivo. Our aim was to investigate a well-characterized sample of adults with confirmed NPC for gray and white matter abnormalities.
significant ultrastructural change to neuronal cell bodies, axons, and dendrites that is associated with significant axonal and neuronal loss. 4, 6 Modern neuroimaging techniques such as MRI can allow for the assessment and monitoring of these changes in vivo, although the relative rarity of adult NPC has meant that few systematic studies have been undertaken. However, no systematic studies have examined regional gray matter changes in patients with NPC to determine if neuroimaging changes match the distribution of the neuropathologic changes reported from animal and human postmortem studies.
We utilized a well-characterized adult NPC cohort and compared them in a crosssectional design against age-and gendermatched controls to explore gray and white matter changes, and hypothesized that we would see significant widespread cortical atrophy, particularly in frontal zones, and widespread disruption to white matter microstructure.
METHODS Standard protocol approval, registration, and patient consent. All participants provided written informed consent and the study was approved by the local research and ethics committee (HREC 2004.042 and 2005.198 ).
Subjects. Data were acquired from 6 adult patients with NPC (4 male, 2 female), all from the Royal Melbourne Hospital, Australia (table 1) , between 2007 and 2009. All adult patients with NPC assessed during this period were included. Diagnosis was confirmed with biochemical analysis of cultured fibroblasts, using cholesterol esterification rate and percentage of cells staining abnormally for perinuclear cholesterol. Patients were matched 3-for-1 for age and gender with healthy controls (n ϭ 18; 11 male, 7 female) without a history of major medical, neurologic, or psychiatric illness, and the study was approved by the local research and ethics committee.
MRI acquisition. All subjects were scanned on a 1.5-T GE Signa MRI machine at the Royal Melbourne Hospital. A volumetric spoiled gradient recalled echo sequence generated 124 contiguous, 1.5-mm coronal slices with echo time (TE)/repetition time (TR) 3.3/14.3 msec; flip angle, 30°; matrix size, 256 ϫ 256; field of view, 24 ϫ 24 cm; voxel dimensions, 0.938 ϫ 0.938 mm. Diffusion tensor imaging (DTI) was undertaken via a 25-direction (one b0 image) echoplanar imaging sequence with 20 axial 5-mm slices, b-value of 1,000; TE/TR 90/6,000 msec; flip angle, 90°; matrix size, 256 ϫ 256; voxel dimensions, 0.938 ϫ 0.938 mm. A numerical code was used to ensure blind analysis of data.
White matter preprocessing. Maps of fractional anisotropy (FA), mean diffusivity (MD), axial diffusivity ( ʈ ϭ 1 , the first eigenvalue), and radial diffusivity (RD, or ϱ ϭ lambda] 2 , the average of the second and third eigenvalues) were generated using the FMRIB Diffusion Toolbox, part of the FSL software package, version 4.1.4. 7 In order to minimize potential false-positive findings caused by misregistration of disease-related morphologic changes in gray and white matter in the NPC group, voxel-wise statistical analysis of the FA data was carried out using tract-based spatial statistics (TBSS), 8 also part of the FSL package. 7 FA images were created by fitting a tensor model to the raw diffusion data using FDT, and the brain extracted using brain extraction tool. All subjects' FA data were then aligned into common space using the nonlinear registration tool FNIRT. Next, the mean FA image was created and thinned to create a mean FA skeleton, which represents the centers of all tracts common to the group. Each subject's aligned FA data were then projected onto this skeleton, to remove the effect of crosssubject spatial variability that remains after the nonlinear registration, and resulting data fed into voxel-wise cross-subject statistics. Subsequently, other relevant DTI output images (MD, axial diffusivity, RD) were projected onto the mean FA skeleton so other diffusivity values could be compared between groups in the same spatial location.
Gray matter preprocessing. Structural data were analyzed with FSL-VBM, a voxel-based analysis carried out with FSL tools. 7 Structural images were brain-extracted and tissue-type segmentation was carried out using FAST4 from the FSL package. Resulting gray-matter partial volume images were then aligned to MNI152 standard space using the affine registration tool FLIRT, 9 followed by nonlinear registration using FNIRT. Resulting images were averaged to create a study-specific template, to which native gray matter images were then nonlinearly reregistered. Registered partial volume images were then modulated (to correct for local expansion or contraction) by dividing by the Jacobian of the warp field. The modulated segmented images were then smoothed with an isotropic Gaussian kernel with a sigma of 3 mm.
Statistical analyses.
Between-group analyses were conducted using Randomize, a permutation-based nonparametric analysis program from the FSL package. We used permutation-based nonparametric inference within the framework of the general linear model to investigate changes in the gray matter, FA, MD, RD, and axial diffusivity between both groups, with thresholdfree cluster enhancement with 5,000 permutations per analysis. Reported results are robust clusters corrected for multiple comparisons across space ( p Ͻ 0.05 corrected). White matter results. Results from TBSS mapping of differences in FA between patients with NPC and controls demonstrated widespread reductions in the patient group bilaterally, affecting most brain regions and projection as well as association fibers (figure 1). There were no regions of increased FA relative to controls. In MD maps, we found significant wide- spread increases that corresponded to regions of FA reduction. Separating diffusivity into its axial (axial diffusivity) and radial (RD) components showed that each was significantly increased in the NPC group (figure 2). Significant clusters were localized using the Johns Hopkins white matter atlas within FSLView 3.1.2. Mean values for FA, MD, RD, and axial diffusivity for representative white matter regions, using region-of-interest masks from the Johns Hopkins atlas on the common TBSS skeleton for patients and controls, are shown in table e-1 on the Neurology ® Web site at www.neurology.org.
RESULTS
Gray matter results. Voxel-based comparison of patients with NPC revealed bilateral and highly significant differences in gray matter volume distribution (patients Ͻ controls) in the planum temporale, Heschl gyrus, and parietal operculum; left and right hippocampus and parahippocampal gyrus; left and right thalamus; right putamen; and anterior/superior cerebellar lobules I-VI (figures 3 and 4). There were no regions of significant increases in gray matter volume. Significant clusters were localized using the Harvard-Oxford cortical and subcortical atlases, and the MNI152 cerebellar atlases, within FSL-View.
DISCUSSION
In a well-characterized sample of adult patients with NPC, we found widespread alterations to white matter microstructure and focal changes in gray matter volume. Our study is the first systematic study of adult patients with NPC that specifically examined gray matter volume in comparison to a control group, and the first to use a whole-brain approach. While DTI has shown promise as a marker of CNS pathology in animal models and as a mechanism to detect change, no statistical analyses of white matter microstructure have previously been undertaken in NPC. We predicted widespread changes in gray matter regions, as has previously been reported in a number of case reports and series in adults, although the presence of such gray matter changes is far from universal and tends to be most apparent late in the illness course. 3, 10, 11 Neocortical regions were generally spared from volumetric change, except for the inferior temporal gyrus, planum temporale, and parietal operculum. The strongest bilateral findings occurred in the insular cortex, hippocampal and parahippocampal regions, bilateral superior cerebellum, thalamic gray matter, and to a lesser extent the striatum. These findings suggest a particular pattern of gray matter volumetric change that may reflect differential vulnerability of certain neuronal populations to the neuropathology of NPC, which may be more apparent in adult patients with NPC due to the less fulminant biochemical disruption and illness course in adults. The reasons for the apparent selective vulnerability of neurons in NPC remain unclear, although animal NPC1 models have been revealing. 6 In NPC1
cats, while abnormal storage products occur in neurons across the CNS, only cerebellar Purkinje neurons are completely lost, 12 suggesting these are the most susceptible. Additionally, while GM2 ganglioside storage varies across cell populations, those cell populations with greatest storage of GM2 are associated with characteristic ectopic dendritic sprouting. 13 Finally, cats with NPC1 disease have been shown to only exhibit axonal spheroids in GABAergic neuronal populations, including cerebellum, brainstem, cerebral cortex (including hippocampus), and basal ganglia. 14 Significant axonal spheroid formation, which occurs in a range of storage disorders, appears to be necessary for clinical neurologic disease. 12 In NPC1 and NPC2 mouse models, intracellular storage of GM2 and GM3 gangliosides is conspicuous in Purkinje cells, large pyramidal neurons, and neurons in the lateral thalamus, hippocampus, and brainstem. [15] [16] [17] In NPC mice, neuronal loss occurs in the cerebellum, as in cats, and Purkinje cells in the cerebellum deteriorate in a stepwise fashion, with neurons in lobules IX and X in the posterior vermis surviving longest. 18 Additionally, significant neuronal loss occurs in the murine thalamus. 16, 19 Finally, one pathology not reported in animal models, but described in human postmortem samples, is the formation of neurofibrillary tangles (NFTs) in basal ganglia, brainstem, cerebral cortex, and hippocampus (particularly CA1 and CA2), [20] [21] [22] but not in cerebellar Purkinje cells. 23 This suggests that the combination of regional ganglioside excess driving altered neuronal morphology and/or loss in the cerebellum, hippocampus, brainstem, thalamus, and cortex may interact with further ultrastructural changes (via altered microtubular function) leading to NFT accumulation in many of the same regions. Overall, our findings in gray matter marry well with these neuropathologic findings from these disparate models, supporting the validity of our findings.
In contrast to relatively selective gray matter findings, white matter changes affected most major tracts. Few studies have probed white matter integrity directly in NPC. Galanaud et al. 24 reported similar baseline alterations in centrum semiovale NAA/ Cre in adult NPC, and an attenuation of abnormal Cho/Cre levels following 24 months' treatment with the substrate reduction therapy miglustat. One report of a pediatric patient with NPC utilized DTI, which indexes the integrity of white matter microstructure. In animal NPC models, DTI has demonstrated reductions in white matter integrity in NPC mice compared to wild-type mice, partially reversible with neurosteroid or cyclodextrin treatment, 25 suggesting it may be a useful biomarker of illness status and treatment response. One report of a pediatric patient with NPC demonstrated marked global reductions in white matter integrity, particularly in the corpus callosum. 26 Despite the widespread use of DTI as a neuroimaging tool to probe illness progression in a range of neurologic disorders, it has not been utilized in adult NPC samples. Alterations in measures such as FA may reflect changes at the level of the axon, or in oligodendrocytes and their investing myelin sheath. There is significant evidence of alterations to axonal structure in NPC, including focal axonal swelling and spheroids, in addition to abnormal axonal branching and the formation of recurrent axonal collaterals. 12, 17, 27 Reduced axonal number may also occur in long association or commissural tracts such as the corpus callosum. 28 This may be the result of reduced transport of cholesterol to distal axons, limiting their growth. 29 Myelination is also severely disrupted, with reduction of myelin-specific proteins suggestive of reduced myelination, rather than destruction of normally formed myelin. 28, 30 In an NPC mouse model, normal myelination was differentially disrupted, being particularly reduced across the callosum, but relatively intact in internal capsules, cerebellar white matter, brainstem, and spinal cord, 31 areas less affected in our study. There is evidence from murine NPC models that reduced myelination is underpinned by reduced differentiation of, and abnormal inclusions within, oligodendrocytes. 32 This suggests a more widespread early pattern of white matter change due to the combination of altered axonal structure and reduced myelination, with a relative sparing of basal white matter structures. This is consistent with our findings of widespread reduction in FA, which may be the result of perturbed axonal structure and organization, and reduced myelination. 33 The increases in radial diffusivity in most regions suggest widespread dysmyelination, 34 while altered axial diffusivity suggests axonal degeneration and/or reorganization, 35 consistent with the neuropathologic models of white matter alterations in NPC.
Most reductions in gray matter were associated with surrounding perturbations to white matter tracts. This may reflect a differential effect of NPC neuropathology on gray and white matter compartments, or it may reflect a relatively early alteration to white matter fiber and sheath structure in NPC, with gray matter changes occurring later. This is supported by a murine NPC model, with evidence that axons are the first affected structures in NPC, with neuronal cell bodies showing much later degeneration, 36 although it should be noted that white matter pathology may be more severe in the Balb/c murine model than in humans and this may partially account for this differential effect. The only in vivo way to confirm this would be through longitudinal neuroimaging analysis. However, we note that our gray matter analysis was volumetric rather than microstructural, and while these measures are related, they do not necessarily change collinearly. As a result, it is possible that a method that focuses on volume distribution of gray matter may fail to detect more widespread microstructural changes that are yet to manifest in gray matter change.
These imaging changes correlate with clinical findings in adults with NPC. Adult patients generally present with ataxia and dystonia, 10 which may relate to cerebellar and striatal changes. While the degree and pattern of neuropsychological impairment may vary considerably in adult patients with NPC, 10, 37, 38 the strong bilateral reductions in hippocampal volume are consistent with the often significant verbal working memory deficits described. 37 However, significant executive disturbance is also described, and we did not demonstrate volumetric changes to frontal cortex in our study, although executive changes could be attributable to superomedial cerebellar alterations. Additionally, the characteristic vertical supranuclear ophthalmoplegia is not reflected in significant brainstem changes in gray and white matter, although the limited resolution of traditional MRI at 1.5-T field strength in this brain region may limit the capacity of registrationdependent, voxel-based approaches to detect change, particularly DTI. 39 However, given that a disproportionate number of adult patients with NPC present with schizophrenia-like psychosis, 3, 11 it is notable that we have shown widespread evidence of anatomic disconnectivity via altered white matter structure in adult NPC, which has been posited as the substrate of the functional disconnectivity believed to underpin schizophrenic symptoms. Furthermore, a number of the gray matter regions in our study-most particularly, the medial temporal lobe, but also including the thalamus and cerebellum-have been strongly implicated in the neuropathology of schizophrenia. Adult NPC, like a number of other adultonset neurometabolic disorders, may present with a schizophrenia-like presentation due to the combination of anatomic disconnectivity and disruption to gray matter structures that play a crucial role in integrating information from higher cortical centers.
This study is affected by a number of limitations. Although this is the first study of its type in this disorder, the sample size of affected adult patients with NPC is small because of the rarity of the disorder. This may limit the generalization of our results to the adult NPC population. The small sample may also limit the power to detect between-group differences, particularly when using a methodologically and statistically conservative neuroimaging analysis. We attempted to mitigate this with a larger matched control sample. In spite of this, we detected widespread changes in white matter structure and a number of changes in gray matter regions. Additionally, while we are examining nonvolumetric microstructural changes in white matter, our methodology limits the assessment of gray matter to volume changes alone, and does not probe cortical microstructural changes. This may limit the comparability of our gray and white matter findings, and future studies using microstructural methodologies that assess both white and gray matter (such as magnetization transfer imaging) may resolve this. Further elucidation of the relationship between gray and white matter changes requires longitudinal imaging across the illness lifespan. Our findings suggest that neuroimaging measures can provide a neurobiologic marker of illness status, which-as in animal NPC modelsmay provide a means for indexing the disease response to emerging treatments in human patients with NPC. 
